Skip to main content

Advertisement

Log in

Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients

  • Letter to the Editors
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Jain SM, Wesson S, Hassanein A, Canova E, Hoy M, Fennell RS, Dharnidharka VR (2004) Nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol 19:467–470

    Article  Google Scholar 

  2. Grobner T (2006) Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104–1108

    Article  CAS  Google Scholar 

  3. Marco MP, Muray S, Betriu A, Craver L, Belart M, Fernandez E (2002) Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients. Nephron 92:499–500

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vikas R. Dharnidharka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dharnidharka, V.R., Wesson, S.K. & Fennell, R.S. Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients. Pediatr Nephrol 22, 1395 (2007). https://doi.org/10.1007/s00467-006-0384-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-006-0384-z

Keywords

Navigation